Atracurium Besylate Injection, Solution
Product Images NDC 55150-216

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Atracurium Besylate (NDC 55150-216). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Auromedics Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (50 mg per 5 mL (10 mg / mL) [single-use vial])

This is a warning about a paralyzing agent drug called Besylate Injection. The drug must be refrigerated between 2° to 8°C (36° to 46°F) and should not be frozen. Upon removal from refrigeration, the drug should be used within 14 days even if re-refrigerated. The drug comes in a 5 mL sterile single-dose vial and is made in India by AUROMEDICS. Facilities must be available for artificial respiration as the drug causes respiratory arrest. The drug is sterile and non-pyrogenic.*

FDA Label Image

Package Label-principal Display Panel (50 mg per 5 mL (10 mg / mL) [single-use vials])

This is a description of a drug called Atracurium Besylate Injection. It comes in single-dose vials with 10mg/mL dosage. The drug is used for intravenous injection and is a paralyzing agent with a warning of respiratory distress. The drug comes with precautionary measures, and each vial contains 0.9 sk byt USP along with other chemicals. The drug needs to be refrigerated at a specific temperature to maintain efficacy.*

FDA Label Image

Package Label-principal Display Panel (10 mg/mL)

This text appears to be a label or instruction for a medication called Atracurium Besylate Injection, USP. The concentration of the medication is 10mg/mL and it is advised to peel off and apply to a syringe. The label also has fields for date and time, as well as a space for the name or initials of the person administering the medication.*

FDA Label Image

Atracurium Besylate Chemical Structure (Atracurium Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.